Reata Pharmaceuticals, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €1.89M -80.7% -€266.04M +4.9% -14,075.0% -110 pp -€171.44M -14.2% -9,070.3% -70 pp
    €9.80M +27.4% -€253.66M +20.0% -2,588.2% +1.6 pp -€199.91M -27.1% -2,039.8% +15 pp
    €7.69M -66.0% -€211.32M -14.6% -2,747.0% -17 pp -€274.15M +29.4% -3,563.7% -26 pp
    €22.62M -50.5% -€247.50M +260.3% -1,094.3% -9.4 pp -€211.94M +199.0% -937.1% -7.8 pp
    €45.71M +11.5% -€68.70M +69.0% -150.3% -0.51 pp -€70.88M +0.2% -155.1% +0.17 pp
    €40.99M -3.6% -€40.66M +665.6% -99.2% -0.87 pp -€70.72M +338.2% -172.5% -1.3 pp
    €42.52M -0.9% -€5.31M +329.4% -12.5% -0.096 pp -€16.14M -57.3% -37.9% +0.50 pp
    €42.92M -3.1% -€1.24M -310.4% -2.9% -0.042 pp -€37.83M -49.9% -88.1% +0.82 pp
    €44.31M +1.5% €587.68K -102.0% 1.3% +0.70 pp -€75.44M +28.9% -170.2% -0.36 pp
    €43.67M -€29.94M -68.6% -€58.53M -134.0%

    Notifications